2024 |
CRISPR Therapeutics AG
|
Lead Independent Director |
500.8 K |
-9.4 % |
2024 |
Inozyme Pharma Inc
|
Chairman of the Board and Chief Executive Officer |
- |
- |
2023 |
CRISPR Therapeutics AG
|
Lead Independent Director |
552.6 K |
-10.7 % |
2022 |
CRISPR Therapeutics AG
|
Lead Independent Director |
618.4 K |
-23.2 % |
2022 |
Inozyme Pharma Inc
|
Chairman of the Board and Chief Executive Officer |
106.4 K |
-43.5 % |
2021 |
CRISPR Therapeutics AG
|
Lead Independent Director |
805.0 K |
-27.7 % |
2021 |
Inozyme Pharma Inc
|
Chairman of the Board |
188.3 K |
-44.4 % |
2020 |
CRISPR Therapeutics AG
|
Independent Director |
1.1 M |
- |
2020 |
Inozyme Pharma Inc
|
Chairman of the Board |
338.7 K |
- |
2019 |
CRISPR Therapeutics AG
|
Independent Director |
- |
- |
2019 |
Inozyme Pharma Inc
|
Chairman of the Board |
- |
- |